‘Problem joints’ linked to worse clinical outcomes in hemophilia A
People with severe hemophilia A who have two or more self-described problem joints — a person-centric characterization of joints…
Articles by Katherine Poinsatte, PhD
Bleeding rates with severe hem A fall with prophylaxis, study finds
Prophylactic, or preventive, treatment with factor VIII (FVIII) replacement therapy for four years reduced annual bleeding rates by 91% for…
Bone mineral density low in hemophilia patients: Study
Bone mineral density, or the amount of mineral in bone tissue, is decreased in 63.1% of people with hemophilia,…
Improved joint health shown with intensive FVIII replacement therapy
Hemophilia patients who received intensive factor VIII (FVIII) replacement therapy for better joint health were nearly five times more…
Use of extended half-life products in hemophilia A raises healthcare costs
Prescriptions for extended half-life products to hemophilia A patients in Japan increased from 2016 to 2020, according to a…
Cost of care higher for older, sicker hemophilia A patients: Study
Brazilian hemophilia A patients who are 19 or older had significantly higher median care costs per patient per year…